title: Maternal and infant outcomes with concurrent treatment of tuberculosis and HIV infection in pregnant women.
authors.forename: Patricia L
authors.initials: PL
authors.lastname: Toro
authors.forename: Karen L
authors.initials: KL
authors.lastname: Schneider
authors.forename: Rosalind J
authors.initials: RJ
authors.lastname: Carter
authors.forename: Elaine J
authors.initials: EJ
authors.lastname: Abrams
authors.forename: Wafaa M
authors.initials: WM
authors.lastname: El-Sadr
authors.forename: Andrea A
authors.initials: AA
authors.lastname: Howard
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D000995:Antitubercular Agents / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications* / Q000188:drug therapy*
chemical_list: D019380:Anti-HIV Agents; D000995:Antitubercular Agents